Alerts will be sent to your verified email
Verify Email
PHARMAID
|
Pharmaids Pharma
|
Kimia Biosciences
|
Auro Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-15.3 % | -335.15 % | 12.83 % |
|
5yr average Equity Multiplier
|
1.31 | 66.02 | 1.84 |
|
5yr Average Asset Turnover Ratio
|
0.18 | 1.14 | 0.8 |
|
5yr Avg Net Profit Margin
|
-26.11 % | -0.67 % | 9.49 % |
|
Price to Book
|
2.72 | 12.26 | 3.21 |
|
P/E
|
0.0 | 14.78 | 132.85 |
|
5yr Avg Cash Conversion Cycle
|
-124.59 Days | -33.97 Days | 80.24 Days |
|
Inventory Days
|
79.26 Days | 101.63 Days | 56.39 Days |
|
Days Receivable
|
54.5 Days | 98.68 Days | 214.37 Days |
|
Days Payable
|
383.86 Days | 171.28 Days | 115.48 Days |
|
5yr Average Interest Coverage Ratio
|
-741.3 | 0.78 | 10.53 |
|
5yr Avg ROCE
|
-21.3 % | 10.6 % | 16.02 % |
|
5yr Avg Operating Profit Margin
|
-35.99 % | 3.89 % | 15.11 % |
|
5 yr average Debt to Equity
|
0.16 | 29.85 | 0.48 |
|
5yr CAGR Net Profit
|
n/a | 13.51 % | -23.84 % |
|
5yr Average Return on Assets
|
-13.12 % | -0.69 % | 7.53 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
32.99 % | 74.94 % | 52.18 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
16.45 % | 0.0 | 0.09 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Pharmaids Pharma
|
Kimia Biosciences
|
Auro Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|